ABSTRACT: | Full Text PDF
OBJECTIVE: To evaluate the efficacy and safety of Glibenclamide and Pioglitazone drugs in type 11 non- insulin dependent diabetes mellitus patients.
STUDY DESIGN: study was prospective, randomized study.
PLACE AND DURATION: This study was conducted in the department of Pharmacololgy and Therapeutics, Muhammad Medical College Mirpurkhas, in collaboration with Medical Outpatient Department of Civil Hospital Dadu, Sindh
PATIENTS, METHOD: Hundred and twenty NIDDM (type-II) diabetic patients were enrolled in the study from the out patient department civil hospital Dadu. All the patients were divided in two groups.
RESULTS: In fasting blood sugar, the mean values of glibenclamide group at the start, six months were 150.5